Skip to main content
Top

2014 | OriginalPaper | Hoofdstuk

Medicamenteus geïnduceerde dysfonie

juli 2006

Auteurs : H.F.M. Peters, R. Bastiaanse, J. Van Borsel, P.H.O. Dejonckere, K. Jansonius-Schultheiss, Sj. Van der Meulen, B.J.E. Mondelaers

Gepubliceerd in: Stemstoornissen

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Bij de bespreking van medicamenteus geïnduceerde dysfonie maken we een onderscheid tussen medicatie die lokaal wordt toegediend, zoals inhalatiecorticosteroïden bij behandeling van astma en medicatie die systemisch wordt toegediend, bijvoorbeeld bij hormonale therapie.
Literatuur
go back to reference Fuchs, M., & Bucheler, M. (2004). Chronic hyperplastic laryngitis following treatment of hypertension with angiotensin converting enzyme-inhibitor. HNO, 52 (11), 998-1000. Fuchs, M., & Bucheler, M. (2004). Chronic hyperplastic laryngitis following treatment of hypertension with angiotensin converting enzyme-inhibitor. HNO, 52 (11), ­998-1000.
go back to reference Gerritsma, E.J., Brocaar, M.P., Hakkesteegt, M.M., & Birkenhager, J.C. (1994). Virilization of the voice in post-menopausal women due to the anabolic nandrolone decanoate (Decadurabolin). The effects of medication for one year. Clinical Otolaryngology and Allied Sciences, 19 (1), 79-84. Gerritsma, E.J., Brocaar, M.P., Hakkesteegt, M.M., & Birkenhager, J.C. (1994). Virilization of the voice in post-menopausal women due to the anabolic nandrolone decanoate (Decadurabolin). The effects of medication for one year. Clinical Otolaryngology and Allied Sciences, 19 (1), 79-84.
go back to reference Hanania, N. A., Chapman, K.R., & Kesten, S. (1995). Adverse effects of inhaled corticosteroids. American Journal of Medicine, 98, 196-208. Hanania, N. A., Chapman, K.R., & Kesten, S. (1995). Adverse effects of inhaled corticosteroids. American Journal of Medicine, 98, 196-208.
go back to reference Ihre, E., Zetterstrom, O., Ihre, E., & Hammaberg, B. (2004). Voice problems as side effects of inhaled corticosteroids in asthma patients- a prevalence study. Journal of Voice, 18, 403-14. Ihre, E., Zetterstrom, O., Ihre, E., & Hammaberg, B. (2004). Voice problems as side effects of inhaled corticosteroids in asthma patients- a prevalence study. Journal of Voice, 18, 403-14.
go back to reference Lavy, J.A., Wood, G., & Rubin, J.S. (2000). Dysphonia associated with inhaled corticosteroids. Journal of Voice, 4, 581-8. Lavy, J.A., Wood, G., & Rubin, J.S. (2000). Dysphonia associated with inhaled corticosteroids. Journal of Voice, 4, 581-8.
go back to reference Petitpain, N., Gambier, N., Gillet, P., Muller, J.C., & de Romemont, E. (2005). Dysphonia induced by selective serotonin reuptake inhibitors. Southern Medical Journal, 98 (8), 843. Petitpain, N., Gambier, N., Gillet, P., Muller, J.C., & de Romemont, E. (2005). Dysphonia induced by selective serotonin reuptake inhibitors. Southern Medical Journal, 98 (8), 843.
go back to reference Roland, N.J., Bhalla, R.K., & Earis, J. (2004). The local side effects of inhaled corticosteroids. Current understanding and review of the literature. Chest, 126, 213-9. Roland, N.J., Bhalla, R.K., & Earis, J. (2004). The local side effects of inhaled corticosteroids. Current understanding and review of the literature. Chest, 126, 213-9.
go back to reference Salzman, G.A., & Pyszczynski, D.R. (1988). Oropharyngeal candidase in patients treated with beclomethasone diprprionate delivered by metered dose inhaler alone and with aerochamber. Journal of Allergy Clinical Immunology, 81, 424-8. Salzman, G.A., & Pyszczynski, D.R. (1988). Oropharyngeal candidase in patients treated with beclomethasone diprprionate delivered by metered dose inhaler alone and with aerochamber. Journal of Allergy Clinical Immunology, 81, 424-8.
go back to reference Spiegel, J.,R., Hawkshaw, M., Sataloff, R. (2000). Dysphonia related to medical therapy. Otolaryngology Clinics of North America 33, 771-84. Spiegel, J.,R., Hawkshaw, M., Sataloff, R. (2000). Dysphonia related to medical therapy. Otolaryngology Clinics of North America 33, 771-84.
go back to reference Toogood, J.H. (1990). Complications of topical steroid therapy for asthma. American Review of Respiratory Diseases, 141, S89-S96. Toogood, J.H. (1990). Complications of topical steroid therapy for asthma. American Review of Respiratory Diseases, 141, S89-S96.
go back to reference Williams, A.J., Baghat, M.S., & Stableforth, D.E. (1983). Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax, 38, 813-21. Williams, A.J., Baghat, M.S., & Stableforth, D.E. (1983). Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax, 38, 813-21.
go back to reference Williamson, I.J., Matusiewicz, S.P., & Brown, P.H. (1995). Frequency of voice problems and cough in patients using pressurized aerosol steroid preparations. European Respirator Journal, 8, 590-2. Williamson, I.J., Matusiewicz, S.P., & Brown, P.H. (1995). Frequency of voice problems and cough in patients using pressurized aerosol steroid preparations. European Respirator Journal, 8, 590-2.
Metagegevens
Titel
Medicamenteus geïnduceerde dysfonie
Auteurs
H.F.M. Peters
R. Bastiaanse
J. Van Borsel
P.H.O. Dejonckere
K. Jansonius-Schultheiss
Sj. Van der Meulen
B.J.E. Mondelaers
Copyright
2014
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-0808-8_21